Showing 2,601 - 2,620 results of 14,705 for search '(( significant increase decrease ) OR ( significantly ((alter decrease) OR (mean decrease)) ))', query time: 0.61s Refine Results
  1. 2601
  2. 2602
  3. 2603

    Supplementary file 2_Gut microbiome and serum metabolome alterations in osteosarcoma patients.xlsx by Chao Li (145513)

    Published 2025
    “…Principal component analysis identified 33 microbial species that exhibited significant changes in osteosarcoma patients. Of note, the relative abundance of Alloprevotella and Prevotella increased in these patients. …”
  4. 2604

    Supplementary file 1_Gut microbiome and serum metabolome alterations in osteosarcoma patients.docx by Chao Li (145513)

    Published 2025
    “…Principal component analysis identified 33 microbial species that exhibited significant changes in osteosarcoma patients. Of note, the relative abundance of Alloprevotella and Prevotella increased in these patients. …”
  5. 2605

    Data Sheet 2_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  6. 2606

    Data Sheet 3_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  7. 2607

    Data Sheet 1_Ruxolitinib synergizes with regulatory T cells to improve inflammation but has no added benefits in decreasing albuminuria in SLE.pdf by Mi-Ae Lyu (20413646)

    Published 2025
    “…The addition of ruxolitinib increases UCB-Treg cell persistence in peripheral blood in vivo and decreases the soluble form of human inflammatory cytokines including IFN-γ, TNF-α, and sCD40L in plasma along with improvement of skin lesions in SLE xenografts. …”
  8. 2608

    Blood test data. by Yasuaki Mushiga (21485741)

    Published 2025
    “…</p><p>Conclusions</p><p>Macular retinal volumes may decrease owing to DM and elevated serum lipid levels. …”
  9. 2609

    Characteristic of the eyes. by Yasuaki Mushiga (21485741)

    Published 2025
    “…</p><p>Conclusions</p><p>Macular retinal volumes may decrease owing to DM and elevated serum lipid levels. …”
  10. 2610

    Raw data of the participants. by Yasuaki Mushiga (21485741)

    Published 2025
    “…</p><p>Conclusions</p><p>Macular retinal volumes may decrease owing to DM and elevated serum lipid levels. …”
  11. 2611
  12. 2612
  13. 2613
  14. 2614
  15. 2615
  16. 2616
  17. 2617

    Table_1_FMT intervention decreases urine 5-HIAA levels: a randomized double-blind controlled study.DOCX by Lihong Wang (14991)

    Published 2024
    “…However, in the placebo group, GSRS, CARS, and SRS scores showed no significant changes, while ABC scores decreased from 72 to 58.75 (p = 0.034). …”
  18. 2618
  19. 2619
  20. 2620